Instil Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Instil Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Instil Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$23M, a 65.9% increase year-over-year.
  • Instil Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$75.2M, a 61.8% increase year-over-year.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$156M, a 30.1% increase from 2022.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 42.3% decline from 2021.
  • Instil Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$157M, a 315% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$75.2M -$23M +$44.4M +65.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$120M -$14.9M +$3.75M +20.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$123M -$24.3M +$32.8M +57.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$156M -$12.9M +$40.9M +76% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$197M -$67.4M -$11.2M -19.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$186M -$18.7M +$40.3M +68.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$226M -$57.1M -$2.95M -5.45% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$223M -$53.8M +$1.51M +2.72% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$225M -$56.2M -$13.2M -30.7% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-11-13
Q2 2022 -$211M -$59M -$23.7M -67.1% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-11-13
Q1 2022 -$188M -$54.1M -$31M -134% Jan 1, 2022 Mar 31, 2022 10-Q/A 2023-11-13
Q4 2021 -$157M -$55.4M -$38.2M -222% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$119M -$43M -$35.7M -492% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$82.9M -$35.3M -$26.1M -284% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$56.8M -$23.1M -$19M -466% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$37.7M -$17.2M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 -$7.26M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$9.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$4.09M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.